CrystalGenomics, Inc is a bioventure company. The company operates in the pharmaceutical industry, focusing on research and development of next generation biopharmaceuticals. CrystalGenomics, Inc. has developed the Acelex 9 and CG 806 medicines and has a large number of employees, including a high percentage of PhD researchers. The company claims to have a significant revenue of 87.4 billion.
Headquarters
5F Tower A,Korea Bio Park 694-1, Sampyeong-Dong, Bundang-Gu, Seongnam-Si
Seongnam; Gyeonggi;
Contact Details: Purchase the Crystal Genomics Inc. report to view the information.
Website: http://www.cgxinc.com
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service